Semaglutide vs. Tirzepatide: Which GLP-1 Medication Is Right for You?
Both medications have transformed weight loss treatment, but they work differently. Here's what the clinical evidence shows and how to choose between them.
How Do These Medications Work?
GLP-1 receptor agonists mimic a natural hormone your body produces after eating. This hormone signals fullness to your brain, slows gastric emptying, and helps regulate blood sugar. Appetite and food-related thoughts can change differently by product, dose, and person. Elimination of food noise is not guaranteed.
Semaglutide (brand names: Wegovy for weight loss, Ozempic for diabetes) targets the GLP-1 receptor. It was approved by the FDA for chronic weight management in June 2021 based on the landmark STEP clinical trial program.
Tirzepatide (brand names: Zepbound for weight loss, Mounjaro for diabetes) targets both the GLP-1 and GIP receptors, a dual-action mechanism. It was approved for weight management in November 2023 based on the SURMOUNT trial program. The dual receptor action may explain why tirzepatide tends to produce greater weight loss in clinical trials.
Clinical Trial Results: Head-to-Head Comparison
Still comparing?
Test the compounded option for one month, $199, before you commit
The Skeptics' Trial includes the physician evaluation and, only if a prescription is approved and the dispensing pharmacy can fulfill it for your location, one month of compounded semaglutide; the pharmacy confirms packaging and shipping details before fulfillment. No long-term commitment. A compounded preparation is a different product from Wegovy or Ozempic: not FDA-approved, not brand-identical, and results vary.
How the 30-day trial works| Feature | Semaglutide | Tirzepatide |
|---|---|---|
| Mechanism | GLP-1 receptor agonist | Dual GLP-1/GIP receptor agonist |
| Key trial | STEP 1 (NEJM, 2021) | SURMOUNT-1 (NEJM, 2022) |
| Average weight loss | 14.9% at 68 weeks, STEP 1 brand trial | 20.9% at 72 weeks, SURMOUNT-1 15 mg brand trial |
| Patients losing ≥20% | ~32% at highest dose | ~57% at highest dose |
| Dosing | Weekly injection | Weekly injection |
| FDA approved for weight loss | June 2021 (Wegovy) | November 2023 (Zepbound) |
| Starting dose | 0.25 mg/week | 2.5 mg/week |
| Max dose | 2.4 mg/week | 15 mg/week |
| Also treats diabetes | Yes (as Ozempic) | Yes (as Mounjaro) |
| Cost at New Hope | From $166/month · just $5.50/day | From $233/month · just $7.70/day |
What Does the Weight Loss Look Like Month by Month?
Both medications follow a dose-titration schedule where you start at a low dose and gradually increase. This minimizes side effects while building toward the therapeutic dose.
Semaglutide typical timeline
Early titration: Dose changes follow the exact prescription, tolerability, and product-specific instructions. Appetite and side effects may change, but no fixed weekly loss should be expected. Later treatment: The clinician reviews tolerability, adherence, nutrition, lean-mass protection, and response before adjusting a plan. Trial averages describe specific studied FDA-approved products and time horizons, not an individual forecast or a compounded-product outcome. Results vary.
Tirzepatide typical timeline
Early titration: Dose changes follow the exact prescription, tolerability, and product-specific instructions. Response cannot be predicted from a calendar. Later treatment: The clinician reviews benefits, side effects, adherence, nutrition, lean-mass protection, and the studied product's labeling before adjusting a plan. Head-to-head and placebo-controlled trial averages are product-specific and do not guarantee an individual or compounded-product result. Results vary.
Side Effects: What to Expect
Both medications share a similar side effect profile, primarily gastrointestinal, and these effects typically decrease over time as your body adjusts and your dose stabilizes.
Common side effects (both): nausea (most common, especially at dose increases), diarrhea, constipation, vomiting, abdominal pain, and decreased appetite. Frequency and duration depend on the approved product, dose, and person. A compounded preparation has no FDA-approved label; symptoms may improve, continue, or worsen.
Less common: injection site reactions, headache, fatigue, dizziness, and heartburn.
Who Qualifies for GLP-1 Medication?
The FDA has approved both medications for adults with a BMI of 30 or higher (obesity), or a BMI of 27 or higher with at least one weight-related condition such as type 2 diabetes, high blood pressure, high cholesterol, or obstructive sleep apnea. Your physician at New Hope Weight Loss evaluates your complete medical history to determine eligibility.
Which Medication Should You Choose?
Consider semaglutide if: you want the most clinically established GLP-1 option with the longest track record, you prefer a lower monthly cost (from $166/mo at New Hope Weight Loss), you want to discuss product-specific evidence and tradeoffs without assuming a particular outcome, or you have type 2 diabetes and want the dual benefit.
Consider tirzepatide if: you want the potential for greater weight loss (20%+ of body weight), you have significant weight to lose, you've tried semaglutide with limited results, or you have type 2 diabetes that's difficult to control with other medications.
The best choice is the one your physician recommends based on your medical history, goals, other medications, and insurance or budget considerations. At New Hope Weight Loss, your doctor evaluates all of these factors during the initial consultation.
Frequently Asked Questions
Which is more effective for weight loss, semaglutide or tirzepatide?
SURMOUNT-1 reported a 20.9% average at 72 weeks for brand tirzepatide 15 mg. STEP 1 studied Wegovy 2.4 mg for 68 weeks. These were separate trials and do not establish an advantage or outcome for compounded preparations. However, individual results vary and your physician will recommend the best option based on your health profile.
How much does semaglutide cost vs. tirzepatide at New Hope Weight Loss?
At New Hope Weight Loss in Costa Mesa, CA, semaglutide programs start at $166 per month and tirzepatide programs start at $233 per month. The initial doctor review and prescription fee is $119 for either medication, medication costs are billed separately. We accept HSA and FSA payments.
Can I switch from semaglutide to tirzepatide?
Yes, switching between GLP-1 medications is possible under physician supervision. Your doctor at New Hope Weight Loss will evaluate your progress and determine if switching medications could improve your results.
What are the main side effects?
Both medications share similar gastrointestinal side effects including nausea, diarrhea, vomiting, and constipation. Timing, severity, and duration vary; persistent or severe symptoms require clinical contact. Both carry an FDA boxed warning about thyroid C-cell tumors. Your physician monitors for side effects and adjusts dosing throughout treatment.
Do I need a prescription?
Yes. Both semaglutide and tirzepatide are prescription-only medications requiring physician evaluation. At New Hope Weight Loss, the doctor review is $119. If you are not approved for treatment, you are not charged for medication.
How long do I need to take GLP-1 medication?
There is no guaranteed individual result or 90-day timeline. Clinical trials ran 68-72 weeks. Your physician will create a personalized treatment plan. Many patients transition to maintenance doses after reaching their goal weight.
Build an options decision record
List the exact products being compared, labeled indications, contraindications, prior response, tolerability, device and concentration, monitoring, access, and complete cost. Separate trials can inform questions but do not predict an individual result or prove that a compounded preparation matches a brand product.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice. Individual results may vary. GLP-1 medications require a prescription and physician supervision. All medical claims are based on published clinical trial data from the STEP and SURMOUNT programs. Consult your healthcare provider before starting any weight loss medication.
New Hope Weight Loss | 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342
Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with, endorsed by, or sponsored by Novo Nordisk or Eli Lilly. Compounded semaglutide and tirzepatide are not FDA-approved or brand-identical and have not undergone FDA premarket review for safety, effectiveness, or quality. Results vary. Any prescription depends on individualized medical review and lawful pharmacy fulfillment for the patient's location.